Pancreatic Cancer

Slow tumor growth in pancreatic cancer by cutting off cell communication

Study how the different cells that make up a pancreatic cancer tumor communicate to promote growth and design a way to cut off this communication.

Cell Therapy Translational Research Laboratory at University of Toronto
Toronto, Canada
Dr. Armand Keating
Lead Researcher

$0

of $60,000 goal

Flexible

info

Flexible Goal

This research will receive all of the funds raised regardless of whether it meets its overall funding goal.

Champion this research!

Champions take a more active role in supporting a research project. They help drive awareness and donations by promoting the project with their network and/or matching donations.

Donate

Kernls helps fund medical science

Kernls is a platform where you can access and donate directly to scientific research projects from top scientists at world-renown institutions. Read our FAQ

Project Start-Up
Help raise $60,000 to get this project launched!

Project Summary

Roughly 90% of cells that make up pancreatic cancer tumors are actually not cancerous. We want to investigate the role of these special cells, called stromal cells, in creating an environment for the tumor to grow so we can disrupt it.

We’ve been studying similar cells derived from bone marrow in our lab for years and want to apply our learnings to pancreatic cancer cells.

At the end of the start-up phase, we anticipate validating our observations and generating a list of potential pancreatic cancer factors that stimulate stromal cells to promote cancer growth that we can investigate further.

timeProject Length9-12 months
targetGoalTo validate our observations and generate a list of factors that stimulate growth that we can investigate further.
bottleResearch TypeExploratory

Why This Research is Important

40,000+

are diagnosed and die from pancreatic cancer in the U.S. every year.

<10%

is the 5 year survival rate for those diagnosed with pancreatic cancer.

There haven't been significant advancements in pancreatic cancer treatment in the last 20 years. We believe the lack of progress in treatments for pancreatic cancer is partly due to the lack of focus on the non-cancerous cells that surround the tumor.

What Funding Helps Achieve

PROJECT START-UP 2021

If the start up phase generates a list of potential tumour generating agents, we will then evaluate each of these factors individually and in combination in promoting the production of IL-6 from the stromal cells and promoting pancreatic cancer cell growth.

Cost of materials, reagents and supplies (33.3%), Hiring a post doctoral fellow (66.6%) = $60,000 (USD)

Research Team

Dr. Armand Keating, MD FRCPC

Lead Researcher

H-Index

 

H-Index reflects how often a researcher's published work is cited by others. It's used as an indication of their impact and productivity.

: 60

Dr. Keating was a Cancer Research Scientist at the National Cancer Institute of Canada for 10 years and a Senior Scientist at the Toronto General Research Institute for many years. He established the largest stem cell transplantation program in Canada at University Health Network, Toronto.

Cell Therapy Translational Research Lab

Toronto, Canada

The Cell Therapy Translational Research Laboratory is part of the University Health Network (UHN). It focuses on developing treatment strategies for cancer and degenerative diseases using immune and other cells of the body.